An official website of the United States government
CDC- BRFSS – ACBS 2022 Adult Prevalence Table 4
| State/Territory | Current | |||
|---|---|---|---|---|
| Sample size± |
% | SE§ | 95% CI† | |
| Arizona | 322 | 34.2 | 5.1 | (24.2 – 44.2) |
| California | 303 | 26.6 | 4.3 | (18.2 – 35.0) |
| Connecticut | 485 | 32.7 | 3.3 | (26.2 – 39.2) |
| Florida | 444 | 35.8 | 4.7 | (26.6 – 45.0) |
| Georgia | 323 | 31.7 | 4.1 | (23.7 – 39.7) |
| Hawaii | 203 | 22.8 | 5.3 | (12.4 – 33.2) |
| Indiana | 473 | 28.1 | 2.6 | (23.0 – 33.2) |
| Iowa | 283 | 33.0 | 4.0 | (25.2 – 40.8) |
| Kansas | 226 | 27.3 | 4.2 | (19.1 – 35.5) |
| Maine | 344 | 40.1 | 4.1 | (32.1 – 48.1) |
| Maryland | 385 | 30.1 | 3.6 | (23.0 – 37.2) |
| Massachusetts | 323 | 34.0 | 3.8 | (26.6 – 41.4) |
| Michigan | 498 | 28.2 | 2.7 | (22.9 – 33.5) |
| Minnesota | 527 | 47.1 | 2.9 | (41.4 – 52.8) |
| Missouri | 235 | 28.1 | 4.1 | (20.1 – 36.1) |
| Nebraska | 158 | 33.8 | 6.0 | (22.0 – 45.6) |
| New Hampshire | 379 | 27.6 | 3.7 | (20.3 – 34.9) |
| New Jersey | 293 | 32.5 | 3.6 | (25.4 – 39.6) |
| New Mexico | 157 | 28.2 | 5.4 | (17.6 – 38.8) |
| New York | 313 | 27.7 | 3.4 | (21.0 – 34.4) |
| Ohio | 399 | 31.4 | 3.6 | (24.3 – 38.5) |
| Oregon | 131 | 33.6 | 5.3 | (23.2 – 44.0) |
| Rhode Island | 237 | 30.7 | 3.9 | (23.1 – 38.3) |
| Texas | 277 | 32.0 | 4.8 | (22.6 – 41.4) |
| Utah | 301 | 26.7 | 3.3 | (20.2 – 33.2) |
| Vermont | 498 | 27.4 | 2.6 | (22.3 – 32.5) |
| Wisconsin | 393 | 30.5 | 3.5 | (23.6 – 37.4) |
| Puerto Rico | 253 | 32.8 | 4.2 | (24.6 – 41.0) |
| 28 States / Area | 9,163 | 30.6 | 1.1 | (28.4 – 32.8) |
| Median | 31.1 | |||
| Range | 22.8-47.1 | |||
1 Aged ≥ 18 years
2 “Yes” response to “Do you still have asthma?”
± Sample size for adults with current asthma, excludes “DK/Refused”
§ Standard error
† Confidence interval
Link for Summary Data Quality Report: https://www.cdc.gov/brfss/acbs/2022/pdf/sdq_report_acbs_22-508.pdf